Onesource Specialty Pharma (ONESOURCE) — Financial Results

📢 Key Event
Q1 FY27 revenue up 37% YoY to ₹4,490 million; EBITDA up 39% YoY to ₹1,233 million; FY28 revenue target $400 million and 40% EBITDA margin reaffirmed; US$100M capex for second sterile line approved.

🔄 What Changed
Revenue and EBITDA growth accelerated YoY; FY28 targets reaffirmed; US$100M capex for capacity doubling approved; 12 regulatory inspections including two FDA audits completed.

🔮 What's Next
FY28 organic revenue target of $400 million and 40% EBITDA margin reaffirmed; new sterile capacity to be operational this quarter and within current financial year; biologics expansion via Formycon partnership ongoing.

💡 Investor Takeaway
The company is scaling capacity and diversifying into biologics to meet FY28 growth targets, with regulatory and commercial momentum supporting long-term margins.

Onesource Specialty Pharma reported Q1 FY27 revenue of ₹4,490 million, up 37% YoY, driven by semaglutide launch and new MSA contracts, with EBITDA rising 39% to ₹1,233 million and 34% sequentially. The company confirmed FY28 organic revenue target of $400 million and 40% EBITDA margin, while advancing US$100 million capex for a second sterile cartridge line to double capacity, alongside biologics expansion via Formycon partnership and 12 successful regulatory inspections including two FDA audits.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ONESOURCE ✨ Ask AI About This

About Onesource Specialty Pharma Limited (ONESOURCE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹17,366.55 Cr ROE: -0.8% ROCE: 0.9%

View full ONESOURCE stock details →

📡 Get AI alerts when ONESOURCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ONESOURCE — Free

💡 Ask AI about this filing

"How will new sterile capacity impact margins beyond FY28?" "What is the revenue contribution timeline for the Formycon biologics partnership?" "How does the $100M capex compare to industry benchmarks for sterile line expansion?"

Ask AI Free →

📊 More ONESOURCE filings

See all ONESOURCE filings →

🔥 Also filed on 31 July 2026

KUANTUM Kuantum Papers Limited Announcement INDIAGLYCO India Glycols Limited Corporate Action TVVISION TV Vision Limited Announcement MARUTI Maruti Suzuki India Limited Financial Results MARUTI Maruti Suzuki India Limited Financial Results RAMRAT Ram Ratna Wires Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ONESOURCE files new disclosures

Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ONESOURCE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd